Musculoskeletal Adverse Events Associated with PCSK9 Inhibitors: Disproportionality Analysis of the FDA Adverse Event Reporting System

por Ding, Lingqing, Chen, Congqin, Yang, Yongkuan, Fang, Jie, Cao, Longxing, Liu, Yige
Publicado 2022